Amgen Patents – Key Insights and Stats

Amgen has a total of 25065 patents globally, out of which 10783 have been granted. Of these 25065 patents, more than 50% patents are active. United States of America is where Amgen has filed the maximum number of patents, followed by Europe and Australia. Parallelly, USA seems to be the main focused R&D center and is also the origin country of Amgen.

Amgen was founded in 1980 by George Rathmann. Amgen is an independent biotechnology medicines company that discovers, develops, manufactures, and markets medicines for grievous illnesses. The Company focuses on human therapeutics and concentrates on innovating novel medicines based on cellular and molecular biology. As of March 2022, Amgen has a market cap of $129.74 Billion.

Do read about some of the most popular patents of Amgen which have been covered by us in this article and also you can find Amgen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Amgen patent portfolio.

How many patents does the CEO of Amgen have?

The CEO, Robert A. Bradway have 1 patent.

How many patents does Amgen have?

Amgen has a total of 25065 patents globally. These patents belong to 3418 unique patent families. Out of 25065 patents, 12561 patents are active.

How many Amgen patents are Alive/Dead?

Worldwide Patents

Amgen Patents Portfolio

Patent Families

Amgen Patents

How Many Patents did Amgen File Every Year?

Amgen Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAmgen Applications FiledAmgen Patents Granted
20111094545
20121292590
2013861670
20141446734
2015918527
2016955606
2017842658
20181219613
20191237637
2020899754
2021554786
2022484

How Many Patents did Amgen File in Different Countries?

Amgen Worldwide Patents

Countries in which Amgen Filed Patents

CountryPatents
United States Of America3493
Europe1982
Australia1836
Japan1819
Canada1192
Mexico905
Germany861
Hong Kong (S.A.R.)753
China702
Israel686
Spain654
Korea (South)618
Singapore617
Taiwan485
Brazil402
Denmark400
India380
Argentina337
Austria331
Portugal322
Eurasian Patent Organization310
New Zealand307
Chile296
Poland266
Malaysia241
Slovenia236
South Africa225
Philippines190
Peru177
Costa Rica165
Uruguay157
Indonesia147
Cyprus142
Hungary137
Serbia121
Croatia116
Norway115
Viet Nam111
Lithuania105
Tunisia95
Morocco95
Ukraine84
Russian Federation81
Jordan64
United Kingdom49
Colombia47
Montenegro47
Czech Republic39
Turkey32
Slovakia27
Bulgaria24
Finland24
Gulf Cooperation Council20
Georgia20
Luxembourg19
Netherlands18
Ecuador16
San Marino16
Iceland15
Europe15
Cuba12
Dominican Republic12
Uzbekistan12
Ireland11
Saudi Arabia10
Thailand9
Estonia9
Macao8
Botswana7
Yugoslavia/Serbia and Montenegro7
Honduras6
Bolivia5
Belarus5
Mongolia5
Brunei5
African Regional Industrial Property Organization8
Nicaragua4
Romania4
El Salvador3
Egypt2
Republic of Moldova2
United Arab Emirates1
Malta1
Belize1
Mozambique1
Belgium1
Greece1
Guatemala1
Kazakhstan1

Where are Research Centers of Amgen Patents Located?

Research Centers of Amgen Patents

10 Best Amgen Patents

WO2009089004A1 is the most popular patent in the Amgen portfolio. It has received 2544 citations so far from companies like Genentech Inc, Novartis and Roche Holding.

Below is the list of 10 most cited patents of Amgen:

Publication NumberCitation Count
WO2009089004A12544
US6660843B11019
US6682736B1940
US20050053973A1654
US6673986B1654
US20050048512A1590
US20040175756A1538
WO2002066470A1536
US20050089932A1510
US6586398B1479

Which Companies are using Amgen Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Amgen patent portfolio are Roche Holding Ag, Regeneron Pharmaceuticals Inc and Genentech.

List of the top forward citing Companies –

CompanyNumber of Patents
Roche Holding Ag35
Regeneron Pharmaceuticals Inc32
Genentech22
Abbvie Inc22
Novartis21
Hcr Collateral Management Llc21
Merck Sharp & Dohme Corp16
Onyx Therapeutics Inc15
Biogen Ma Inc12
Hanmi Science Co Ltd12

Count of 102 and 103 Type Rejections based on Amgen Patents

Top Amgen Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US7648702B225
US8592562B221
US6660843B119
US10474162B216
US20040248299A115
US7705130B212
US7459502B212
US6541610B112
US7829595B211
US7288251B211
US20130064825A111
US6774106B210
US20090317456A110
US7737112B29
US7498420B29

What Percentage of Amgen US Patent Applications were Granted?

Amgen (Excluding its subsidiaries) has filed 2454 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1296 have been granted leading to a grant rate of 70.05%.

Below are the key stats of Amgen’s patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Amgen?

Law FirmTotal ApplicationsSuccess Rate
Amgen Inc96072.91%
Marshall Gerstein & Borun Llp27974.60%
Richard Aron Osman7493.15%
Mcdonnell Boehnen Hulbert & Berghoff6863.64%
Jones Day5665.00%
Finnegan Henderson Farabow Garrett & Dunner5047.83%
Kilpatrick Townsend & Stockton4820.00%
Jones Day For Celgene Corporation4595.56%
Foley & Lardner Llp2555.56%
Banner & Witcoff2281.82%

EXCLUSIVE INSIGHTS COMING SOON!

What are Amgen’s key innovation segments?

What Technologies are Covered by Amgen?

The chart below distributes patents filed by Amgen in different countries on the basis of the technology protected in patents. It also represents the markets where Amgen thinks it’s important to protect particular technology inventions.

R&D Focus: How Amgen search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Amgen?

Updated on March 7, 2022

Was this article helpful?

Leave a Comment